Print

Biodesix, Inc.' Paul Beresford Joins 2012 Biotechnology Industry Organization (BIO) Panel for Personalized Medicine Commercialization  
6/5/2012 10:42:07 AM

BOULDER, Colo.--(BUSINESS WIRE)--Biodesix, Inc., a fully integrated molecular diagnostics company dedicated to personalizing medicine, today announced that Paul Beresford, Ph.D., Vice President of Business Development and Strategic Marketing, will join industry veterans on a panel discussing the recipe for the successful commercialization of personalized medicine at the 2012 BIO International Conference being held in Boston, Mass. June 18-21, 2012.
//-->